RAF1 and neoplasm: Recently, aspirin has been demonstrated to have effective anti-tumor effects against RAS/RAF-mutant cells in colorectal cancer by simultaneously affecting BRAF/CRAF dimerization and hyper-activating the AMPK and ERK pathway [(254); Table 2 and Figure 2].